2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3254
  



  

  
Submitter : 
  

  
Mrs. Katherine Fredal
  

  
Date & Time: 
  

  
12/14/2006 01:12:50
  



  

  
Organization : 
  

  
Mrs. Katherine Fredal
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Please issue guidelines to pharmaceutical companies which will restrict their use of stem cell lines from aborted fetuses, since there are non- objectionable cell lines which can be used in vaccines.